Given our findings that miR-23a-5p is downregulated in COPD patients and that this miRNA has inhibitory effects on RAGE levels in vivo and in vitro, we next investigated whether miR-23a-5p could potentially confer therapeutic effects in mice with COPD. Here, AGER is linked to chronic obstructive pulmonary disease.